OpenLegislation

Division (3) Classification of two products containing cannabidiol (CBD) (Request by the Secretariat) Doc. NC2728EaX1

United Kingdom

Original text. Later amendments are not shown.

The Union shall propose to send the matter to the Scientific Sub-Committee, requesting information on (i) whether the products have enough active ingredients to give a therapeutic or prophylactic effect; and (ii) the minimum amount of CBD as active ingredient in any product to have a therapeutic or prophylactic effect.

Annotations

Editorial notes

X1

Substituted by Corrigendum to Council Decision (EU) 2020/1410 of 25 September 2020 on the position to be taken, on behalf of the European Union, in the 66th session of the Harmonized System Committee of the World Customs Organization in relation to the envisaged adoption of Classification opinions, classification decisions, amendments to the Harmonized System Explanatory Notes or other advice on the interpretation of the Harmonized System, and of recommendations to secure uniformity in the interpretation of the Harmonized System under the Harmonized System Convention (Official Journal of the European Union L 327 of 8 October 2020).